Academic Jobs - Home of Higher Ed Logo

NUS and A*STAR Researchers Unveil De-Saturated Copper Single-Atom Catalysts Achieving 94% Yields in Key Pharmaceutical Reactions

Submit News
brown starfish on blue sand
Photo by Amy Humphries on Unsplash

Collaborative Innovation at Singapore’s Leading Institutions

The National University of Singapore (NUS) and the Agency for Science, Technology and Research (A*STAR) have jointly unveiled a significant advancement in catalyst technology. Researchers from both organizations introduced de-saturated copper single-atom catalysts, known as De-sat Cu SACs, that deliver yields reaching 94 percent in propargylic substitution reactions. These reactions play a central role in synthesizing active pharmaceutical ingredients.

Single-atom catalysts position individual metal atoms on a support material, maximizing atom efficiency while minimizing waste compared with traditional nanoparticle or homogeneous catalysts. The de-saturation approach modifies the electronic environment around each copper atom, enhancing reactivity and selectivity without requiring harsh reaction conditions.

Understanding the Science Behind De-Saturated Copper SACs

Propargylic substitution reactions involve replacing a leaving group attached to a carbon next to a triple bond. These transformations are valuable in pharmaceutical manufacturing because they allow precise construction of complex molecular frameworks found in many drug candidates. The new catalysts tolerate a wide range of nucleophiles, including nitrogen- and carbon-based species, making them versatile for multiple synthetic routes.

The team combined an anchoring-borrowing strategy with facet engineering of the support material. This method stabilizes the copper atoms while allowing dynamic adjustment of their coordination environment during catalysis. The result is improved turnover numbers and sustained performance over multiple reaction cycles.

Implications for Singapore’s Pharmaceutical and Research Ecosystem

Singapore has positioned itself as a global hub for biomedical sciences and advanced manufacturing. High-yield, selective catalysts like these De-sat Cu SACs can reduce production costs, lower solvent use, and shorten development timelines for new medicines. Local pharmaceutical companies and contract manufacturing organizations stand to benefit from more efficient synthetic pathways that align with green chemistry principles.

The breakthrough also reinforces Singapore’s commitment to sustainable chemical processes. By enabling reactions at milder temperatures and with fewer by-products, the technology supports national goals for environmental responsibility in industry.

macro photography of crhistmas star ornament lot

Photo by CHUTTERSNAP on Unsplash

Training the Next Generation of Researchers

Collaborations between NUS and A*STAR provide PhD students and postdoctoral researchers with direct access to cutting-edge facilities and interdisciplinary teams. Students working on single-atom catalyst projects gain expertise in materials characterization, computational modeling, and reaction engineering—skills highly sought after in both academia and industry.

Such hands-on experience prepares graduates for roles in Singapore’s growing research and development sector, where demand for specialists in catalysis, nanotechnology, and sustainable chemistry continues to rise.

Broader Impact on Higher Education and Knowledge Transfer

Breakthroughs originating from university–research institute partnerships often feed directly into teaching curricula. Updated case studies on single-atom catalysts can enrich undergraduate and postgraduate courses in chemistry, chemical engineering, and materials science at NUS and other Singapore institutions.

Knowledge transfer extends beyond the classroom through seminars, workshops, and industry-academia forums hosted by A*STAR and NUS. These platforms help translate laboratory discoveries into practical applications while exposing students to real-world problem-solving.

Future Outlook and Ongoing Developments

Researchers are now exploring scale-up routes for the De-sat Cu SACs and testing their performance across additional reaction classes. Continued refinement could expand their utility to other high-value transformations in fine chemicals and agrochemicals.

Singapore’s strategic investments in research infrastructure position the country to remain at the forefront of catalyst innovation. Future projects may integrate artificial intelligence for catalyst design, further accelerating discovery cycles.

Opportunities for Academics and Job Seekers

The success of this NUS–A*STAR collaboration highlights growing demand for faculty and research staff specializing in catalysis and sustainable chemistry. Institutions across Singapore continue to recruit talent capable of leading similar high-impact projects.

PhD-track candidates interested in these fields can explore funded positions and fellowships that combine academic training with industry exposure, offering clear pathways into both research and applied roles.

Portrait of Dr. Oliver Fenton
About the author

Dr. Oliver FentonView author

Academic Jobs In House Author

Acknowledgements:

Discussion

Sort by:

Be the first to comment on this article!

You

Please keep comments respectful and on-topic.

New0 comments

Join the conversation!

Add your comments now!

Have your say

Engagement level

Browse by Faculty

Browse by Subject

Frequently Asked Questions

🔬What are single-atom catalysts and why do they matter?

Single-atom catalysts consist of isolated metal atoms anchored on a support, offering maximum atom utilization and precise active sites. They bridge homogeneous and heterogeneous catalysis, enabling greener, more selective reactions in pharmaceutical production.

⚗️How do de-saturated copper SACs differ from conventional catalysts?

De-saturation modifies the electronic structure around each copper atom, improving reactivity and stability. This allows high yields in propargylic substitutions while maintaining performance over repeated use, unlike many traditional catalysts that degrade quickly.

💊What pharmaceutical reactions benefit from this breakthrough?

Propargylic substitution reactions are key for building complex drug molecules. The new catalysts tolerate diverse nucleophiles and deliver up to 94% yields, streamlining synthesis of active pharmaceutical ingredients.

🎓How does this research strengthen Singapore higher education?

The NUS-A*STAR partnership provides students and researchers with hands-on experience in advanced materials and catalysis, enriching curricula and preparing graduates for careers in Singapore’s biomedical and chemical industries.

💼Are there career opportunities linked to this technology?

Yes. Growing demand exists for faculty, postdoctoral researchers, and industry scientists skilled in catalyst design, sustainable chemistry, and pharmaceutical process development across Singapore universities and research institutes.

🤝What makes the NUS-A*STAR collaboration unique?

The partnership combines NUS academic expertise with A*STAR’s translational research capabilities, enabling rapid movement from fundamental discovery to potential industrial application while training the next generation of scientists.

🌱How sustainable are these catalysts for large-scale use?

The catalysts demonstrate excellent stability across multiple reaction cycles with minimal degradation, supporting greener manufacturing processes that reduce waste and energy consumption in pharmaceutical production.

📚Will this technology appear in university teaching soon?

Updated case studies on single-atom catalysts are likely to enter NUS and other Singapore chemistry and engineering courses, giving students early exposure to cutting-edge research with real industrial relevance.

🔭What future research directions are expected?

Teams are exploring scale-up methods, broader reaction scope, and integration with computational design tools to accelerate discovery of new single-atom catalysts for additional high-value chemical transformations.

🌍How can international readers engage with Singapore research?

Collaborative programs, visiting fellowships, and industry partnerships facilitated by NUS and A*STAR offer pathways for global academics and students to participate in ongoing catalyst and pharmaceutical research initiatives.